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The Lubrol-soluble adenylate cyclase activity of brain synaptosomal membranes appeared, upon gel filtra- 
tion or sucrose gradient centrifugation, as two overlapping peaks. Fractions corresponding to the peak of 
the largest Stokes radius (Biogel pool 1) or highest s value (gradient pool 1) contained an adenylate cyclase 
activity which could be detected whatever the enzyme assay conditions. In contrast, in fractions from the 
second peak (Biogel pool 2 or gradient pool 2), forskolin was needed to reveal adenylate cyclase activity. 
The enzyme activity of each Biogel pool was retained by forskolin-agarose and eluted by forskolin with 
a 3483% yield. A polypeptide of 155 kDa made up 80% of the forskolin-agarose luate 1, whereas it was 
almost absent from eluate 2. Since data from various groups point to the 155 kDa polypeptide as a brain 
adenylate cyclase catalyst, still another distinct catalyst of lower molecular mass is likely to be present in 
brain. 
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1. INTRODUCTION 
Eukaryotic adenylate cyclase is a membrane- 
bound, multi-component enzyme composed of 
fairly well-known regulatory subunits and of a 
catalyst [1,2]. Purification of the catalyst did not 
progress until very recently. Yeast adenylate 
cyclase has been purified and its gene sequenced 
[3]; mammalian adenylate cyclase has been partial- 
ly purified by several groups within the last year 
[4-81. One methodology took advantage of the af- 
finity of the brain catalyst for Ca*+-calmodulin 
and involved the use of Lubrol [4,5], whereas the 
other relied on its affinity for forskolin and in- 
volved the use of Lubro and Tween [6,8]. With the 
first method, the purified polypeptide was 
135-150 kDa, with the second method 
116-150 kDa. It is still not known whether the 
discrepancies in apparent molecular mass are 
merely due to the use of different detergents, dif- 
ferent gel systems and gel calibration in various 
laboratories, or if they relate to distinct adenylate 
cyclase catalysts. In this respect, it has long been 
known that two forms of adenylate cyclase activity 
exist in the nervous system of higher organisms, 
one which is stimulated by Ca*+-calmodulin, and 
the other, which is independent of Ca*+-cal- 
modulin [9,10]. Besides, the existence of mutant 
files having defects in the calmodulin-dependent 
adenylate-cyclase activity, but not in the cal- 
modulin-independent activity, favours the view 
that there is more than one species of adenylate 
cyclase catalyst [ 11,121. 
Here, we show that gel filtration and sucrose 
density centrifugation of Lubrol-soluble brain 
adenylate cyclase allow one to distinguish two 
forms of enzyme activity which differ by their 
Stokes radii and s values, and by their regulation. 
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2. MATERIALS AND METHODS 
Materials and methods were as described by 
D’Alayer et al. [ 131 and Coussen et al. [4], with 
minor modifications. Briefly, rat brain synap- 
tosomes were prepared by flotation and lysed 
once. All preparative buffers lacked metal 
chelators. Membranes were solubilized with 
Lubrol (0.9%). The supernatant was layered on a 
Biogel A5m column (2.8 mg protein/ml) (7 ml) or 
on sucrose density gradients (0.12 ml), as de- 
scribed [ 131. The elution buffer or sucrose gradient 
solutions were identical, except for sucrose (buffer 
A: 50 mM triethanolamine, pH 8.0,0.05% Lubrol 
PX, 1 mM MgC12, 2 mM EDTA, 75 mM sucrose, 
0.1 mg/l leupeptin and aprotinin, 0.1 mM phenyl- 
methylsulfonyl fluoride, 2 mM dithiothreitol). 
Gradient and column fractions were assayed for 
protein, and for adenylate cyclase activity in the 
presence of 0.1 mM forskolin, 10 mM MgClz and 
2 mM MnC12, or in the presence of 0.2 mM 
EGTA, 0.25 mM CaC12, 10 mM MgCl2 and 2 mM 
MnC12, and 0 or 1 PM calmodulin, as in [4]. 
On the basis of the calmodulin dependence of 
the enzyme, the Biogel eluate fractions were 
pooled: Biogel pool 1 (ml 26 to ml 45), containing 
most of the calmodulin-sensitive adenylate cyclase 
activity, and Biogel pool 2 (ml 52 to ml 62), mostly 
containing calmodulin-insensitive activity. Each 
pool, brought to 0.4 M NaCl, 1 mM MgCL, 
1 mg/l aprotinin and 1 mg/l leupeptin, was in- 
cubated overnight at 4°C with 1.5 ml forskolin- 
agarose on a roller. The slurry was poured into a 
column, and the resin washed with 100 ml buffer 
B (same buffer as above, complemented with 
0.5 M NaCl), 100 ml buffer C (buffer B com- 
plemented with 2 M NaCl) and 10 ml buffer B. 
Adenylate cyclase was eluted by incubating the 
resin at 4”C, 4 times consecutively, 30 min each, 
with 4 ml buffer B containing 0.1 mM forskolin. 
Fractions were assayed for adenylate cyclase activi- 
ty and precipitated with 15% cold trichloroacetic 
acid. The pellets were washed with cold acetone, 
dissolved and subjected to PAGE as described 
[13], except that 7.5-12% acrylamide gels were 
prepared according to Neville [ 141. Gels were 
stained by the silver method [15] or with 
Coomassie blue, and scanned. The protein content 
of the scanned bands was obtained by comparison 
with bands corresponding to known amounts of 
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molecular mass marker proteins analyzed on the 
same gel. 
Adenylate cyclase assays were performed ac- 
cording to Coussen et al. [4] and proteins were 
determined according to Schaffner and 
Weissmann [ 161. The forskolin-agarose was 
prepared according to Pfeuffer et al. [7]. 
3. RESULTS 
3.1. Evidence for two forms of Lubrol-soluble 
adenylate cyciase activity 
The distribution of adenylate cyclase activity 
contained in Lubrol-solubilized brain membranes 
was studied in Biogel eluates and sucrose gra- 
dients. It was fohnd to depend on the enzyme assay 
conditions. 
In the Biogel eluate, a peak of enzyme activity 
was contained in the void volume and, being of 
low specific activity, was not studied. In the in- 
cluded volume, basal activity (measured in the 
presence of either 10 mM MgC12, or 10 mM MgC12 
and 2 mM MnClz), and activity supported by 1 PM 
calmodulin (fig.lA) or 0.1 mM guanylyl im- 
idodiphosphate and 0.2 M ammonium sulfate, or 
1 mg/ml asolectin (not shown), were present in 
fractions corresponding to large Stokes radii 
(lo-12 nm) and appeared as a rather sharp peak. 
In contrast, forskolin-supported activity covered a 
broader region of the eluate, with a first peak 
superimposable on the calmodulin-dependent 
peak, and a second, overlapping one, of smaller 
Stokes radii (7.5-8.5 nm) and representing 
60-65% of the adenylate cyclase present in the in- 
cluded volume (fig.lA). This distribution was not 
affected when EDTA-washed membranes [4], 
rather than control membranes, were used, or if 
the Lubrol concentration of buffers was lowered to 
0.01% (not shown). Fractions were pooled as 
described (section 2). Upon gel filtration on the 
same column of Biogel pool 1, adenylate cyclase 
activity was found only in the fractions of largest 
Stokes radii (lo-12 nm); for Biogel pool 2, the ac- 
tivity was found only in fractions of Stokes radii of 
7.5-8.5 nm. Each form of adenylate cyclase activi- 
ty thus appeared to correspond to stable protein 
associations. 
A somewhat comparable distribution of enzyme 
activity was found in sucrose gradients. Forskolin- 
assayed adenylate cyclase activity appeared as a 
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Fig.1. Distribution of adenylate cyclase in the eluate of 
a Biogel A5m column (A) and in fractions from a 
sucrose gradient (B). 7 ml Lubrol supernatant (A) and 
0.12 ml (B) were analyzed as described in section 2. In 
A, fractions 1-16 ml correspond to the void volume. 
Adenylate cyclase activity was measured in the presence 
of: (H) 0.1 mM forskolin, (M) 0.1 CM 
calmodulin and EGTA-Ca” buffer, as described, 
(M) EGTA-Ca” buffer only. Arrows indicate: (A) 
Stokes radius markers (pig thyroglobulin, 9.8 nm; fl- 
galactosidase, 8.2 nm; catalase, 5.2 nm). (B) 
Sedimentation coefficient markers (catalase, 11.3 S; 
alcohol dehydrogenase, 7.4 S). 
broad peak of sedimentation coefficient 8.8 S, 
whereas in the absence of forskolin, basal activity 
and activity supported by 1 ,uM calmodulin 
covered a more restricted part of the gradient, in a 
higher s value region (10 S) (fig.lB). 
Two forms of adenylate cyclase activity were 
thus identified by differences in both effector 
regulation and physico-chemical parameters. 
3.2. Partial purification of adenylate cyclase on a 
forskolin-agarose column 
Each Biogel pool was incubated with forskolin- 
agarose, and the adenylate cyclase activity was 
eluted in the presence of 0.1 mM forskolin, as 
described. From 34 to 83% of the total activity 
contained in each Biogel pool applied to the resin 
was recovered in the corresponding eluate, 
whatever the Biogel pool (table 1). As analyzed by 
PAGE, the proteins of eluates 1 and 2 were strik- 
ingly different. In eluate 1, one polypeptide of 
155 kDa reproducibly constituted 80-100% of the 
protein content of the fraction, as measured by 
densitometry of gels stained with Coomassie blue. 
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Fig.2. Protein patterns of forskolin-agarose eluates 1 
and 2. Aliquots of eluates 1 (A) and 2 (B) containing the 
same amount of adenylate cyclase activity (2.3 nmol 
CAMP. min-r) were analysed by PAGE. The gel was 
silver-stained [ 151. Arrows point to molecular mass 
markers (200 kDa, myosin; 115 kDa, @-galactosidase; 
60 kDa, catalase; 36 kDa, glucosed-phosphate 
dehydrogenase). 
Low amounts of proteins of 115, 105, 90, 70-74, 
52-56 and 44 kDa were also present. In eluate 2, 
the 155 kDa polypeptide was present in very low 
amounts or undetectable, and proteins of 115, 105, 
90, 52 and 44 kDa were the major components. 
Table 1 gives the yield and purification of 
adenylate cyclase activity achieved, in 4 ex- 
periments, for both forms of the enzyme. Since the 
protein content of the fraction most enriched in 
adenylate cyclase activity was deduced from den- 
sitometry of the gels, the final protein yields and 
specific activities are only approximate. If the 
155 kDa polypeptide present in eluate 1 is indeed 
the adenylate cyclase catalytic subunit, as pro- 
posed [4-61, its specific activity would be 16.8 f 
10 pm01 -mg-’ - min-‘, and its turnover number 
215 
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Table 1 
Purification of adenylate cyclase catalysts 
Protein= 
(mg) 
Purified brain membranes 39.2 + 9.1 
Lubrol-solubilized membranes 35.1 f 5.3 
Supernatant 19.6 f 0.8 
Biogel pool 1 2.1 f 0.2 
Eluate 1 0.0016 f 0.0003 
Biogel pool 2 2.5 f 0.2 
Eluate 2 0.0027 + 0.0005 
Enzyme 
total activitya 
(nmol . min-‘) 
118.8 f 39.0 100 3 1 
190.6 f 32.4 162.5 5.5 1.8 
158.9 f 34.5 134 7.6 2.5 
40.5 + 5.0 34 18.8 6.2 
33.6 + 20.2 28 21000 6930 
43.7 f 5.8 37 17.5 5.8 
15.0 f 1.4 13 5550 1833 
Enzyme 
total recovery 
(%) 
Enzyme Purification 
specific activity (-fold) 
(nmol . mg-’ . 
min-‘) 
a Mean of 4 experiments 
Adenylate cyclase activities were measured in the presence of 0.1 mM forskolin 
would be about 3000. In eluate 2, the polypeptide 
responsible for the adenylate cyclase activity was 
not identified. The specific enzyme activity of this 
fraction was 5.5 f 0.9 pmol.mg-’ emin-‘. 
4. DISCUSSION 
It has been known for a long time that two 
forms of adenylate cyclase activity can be 
distinguished in brain on the basis of their response 
to Ca2+-calmodulin [9,10]. This study is however 
the first to show that, upon solubilization, each 
form of activity is associated with proteins, or pro- 
tein complexes, of different physico-chemical 
parameters: s values, Stokes radii. These forms did 
not appear to be interconvertible. 
In this study, the calmodulin-sensitive form of 
activity found in Biogel pool 1 could be activated 
by guanylyl imidodiphosphate, hence G, cy- 
subunits were associated with at least some 
catalytic subunits. The enzyme activity was 
purified lOOO-fold by affinity chromatography on 
forskolin-agarose, yielding a 155 kDa polypeptide. 
The final fraction obtained here, and that in a 
previous study based upon the use of calmodulin 
affinity chromatography, were comparable in that 
they both yielded a 135-155 kDa polypeptide as 
the major component [4]. The specific activity 
previously attained by us [4] and by Yeager et al. 
[5] was however much lower than that reported 
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here, suggesting either the copurification of an in- 
hibitor of the enzyme activity, or the partial inac- 
tivation of the catalyst. The purification described 
here represents a considerable improvement with 
respect to both specific activity and recovery. 
The occurrence of another form of enzyme ac- 
tivity, found in a fraction devoid of the 155 kDa 
polypeptide, suggests that still another type of 
adenylate cyclase catalyst exists in brain. Could 
this catalyst derive from the 155 kDa polypeptide 
by limited proteolysis which would remove the 
calmodulin-binding and possibly the G, a-binding 
domains? Great care was taken to avoid pro- 
teolysis all along the purification steps, but this 
hypothesis cannot be rejected [13]. A further 
purification of the second form of catalyst is in 
progress. However, the cloning and sequencing of 
the cDNA specific for the 155 kDa polypeptide are 
clearly the next and very important goal to achieve, 
and should really be crucial in establishing the ex- 
istence of one or two distinct catalysts. 
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